Short Michael John

CHRW President Short sells 6,368 shares at $201.30; current price $196.33 near 52-week high

Michael John, President of Global Forwarding at C. H. Robinson Worldwide, sold 6,368 shares at $201.30 on 2026-02-09, reducing holdings by 10.9% to 52,101 shares post-transaction. The sale occurred near the 52-week high (currently -2.1% from peak of $200.59), and the stock has gained 13.8% over the prior 30 days and 29.4% over 90 days. Examining his prior trades at CHRW specifically, only 2 of 5 prior sells showed negative 90-day returns (well-timed for sells), suggesting inconsistent timing success at this ticker. His cross-ticker track record shows a 40.00% well-timed rate on sells with an average 90-day post-sale return of +4.4%, indicating his sales historically have not prevented subsequent gains. The combination of a large reduction in holdings at elevated prices, strong recent price momentum, and a mixed track record of timing on this specific stock warrants observation of the company's fundamentals and further insider trading patterns.

President Short sold 6,364 CHRW shares at $117.24; stock near 52-week high (+17.8% in 30d).

Michael John, President of Global Forwarding, sold 6,364 shares at $117.24 on 2025-08-06, reducing his holdings by 9.5% to 60,401 shares. The sale occurred near the 52-week high of $117.82, with the stock up 17.8% over the prior 30 days and 31.3% over 90 days. His same-ticker history at CHRW shows 2 of 4 prior sales were well-timed at the 90-day mark, with one notably well-timed sale on 2024-11-11 followed by a 90-day decline of -12.1%. The current valuation (P/E of 25.84) and modest annual revenue growth of +0.7% provide context for evaluating insider positioning. The coincidence of a significant sale at market strength and historical pattern of selective timing merits observation of post-transaction price action.

President Michael Short sold 12,209 CHRW shares at $99.58 for $1.2M, reducing holdings 16.8% on 2025-02-18.

Michael John, President of Global Forwarding at C. H. Robinson, sold 12,209 shares at $99.58 on 2025-02-18, reducing his position from 72,495 shares to 60,286 shares. His prior three trades at CHRW show mixed timing: two of three prior sells achieved negative 90-day returns (-0.7% and -12.1%, both well-timed), while one sale in August 2024 resulted in a +9.7% 90-day gain. The current stock price of $100.42 is -12.0% from its 52-week high and down 4.7% over 30 days, reflecting recent weakness. While the sale reduces his holdings substantially (16.8%), the limited context around this particular transaction—coupled with moderate valuation metrics (P/E 24.43, flat annual revenue growth at +0.7%)—suggests modest material significance rather than a clear directional signal.

Michael John sold 10,408 CHRW shares at $109.87 for $1,143,492.61; now at $111.68 (trading near 52-week high)

Michael John, President of Global Forwarding at C. H. Robinson, sold 10,408 shares at $109.87 on 2024-11-11 when the stock was trading 1.6% below its current price of $111.68. The sale reduced his holdings by 12.8%, from 81,351 to 70,943 shares. CHRW is near its 52-week high of $111.68 and has risen 14.2% over 90 days. His prior two sales at CHRW yielded mixed timing outcomes: the 2024-08-09 sale was poorly timed (stock rose 9.7% in the 90-day period), while the 2023-05-04 sale was well-timed (stock fell 6.8% in the 90 days after). Cross-ticker, his track record shows 2 prior sales with an average 90-day return of 1.4% and a well-timed rate of 50%. Against the backdrop of a 37.99 P/E and -28.8% annual revenue decline, the timing of this sale near recent highs merits observation.

Michael John (CHRW President, Global Forwarding) sold 10,894 shares at $98.38; stock up 13.8% in 30 days.

Michael John sold 10,894 shares of CHRW on 2024-08-09 for a total value of $1,071,762.61, reducing his holdings by 13.3% from 81,837 to 70,943 shares. At the time of sale, the stock was trading near its 52-week highs ($102.21 max vs $98.38 sale price, -3.4% from the high). Since the sale, CHRW has appreciated 13.8% over 30 days and 17.7% over 90 days, following a pattern consistent with his prior CHRW sale in May 2023, which also saw negative 90-day returns (-6.8%). However, the company's fundamentals show material headwinds: annual revenue declined 28.8% year-over-year despite a $4.5B quarterly revenue base, and the stock's P/E of 34.88 is elevated relative to the recent downside context. The post-trade stock appreciation reflects market sentiment diverging from the recent company-level revenue contraction trends.